ATE322547T1
(de)
|
1993-06-10 |
2006-04-15 |
Genetic Therapy Inc |
Adenovirale vektoren für die behandlung der hämophilie
|
JP3816518B2
(ja)
*
|
1994-06-10 |
2006-08-30 |
ジェンベク、インコーポレイティッド |
相補的なアデノウイルスベクター系と細胞系
|
US5756283A
(en)
*
|
1995-06-05 |
1998-05-26 |
The Trustees Of The University Of Pennsylvania |
Method for improved production of recombinant adeno-associated viruses for gene therapy
|
US6281010B1
(en)
*
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
US6004797A
(en)
*
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
US6730662B1
(en)
|
1996-07-05 |
2004-05-04 |
Mcgill University |
Adenovirus E4 proteins for inducing cell death
|
JP2000515504A
(ja)
*
|
1996-07-05 |
2000-11-21 |
フィリップ イー. ブラントン |
細胞死を誘導するアデノウイルスe4蛋白質
|
JP4350800B2
(ja)
*
|
1996-09-25 |
2009-10-21 |
ノバルティス アクチエンゲゼルシャフト |
高キャパシティーアデノウイルスベクターの開発の促進に使用するためのパッケージング細胞系
|
US7232899B2
(en)
|
1996-09-25 |
2007-06-19 |
The Scripps Research Institute |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
US6261823B1
(en)
|
1996-12-13 |
2001-07-17 |
Schering Corporation |
Methods for purifying viruses
|
US6168944B1
(en)
|
1997-01-31 |
2001-01-02 |
Schering Corporation |
Methods for cultivating cells and propagating viruses
|
US6146891A
(en)
*
|
1997-01-31 |
2000-11-14 |
Schering Corporation |
Methods for cultivating cells and propagating viruses
|
JP2000509614A
(ja)
*
|
1997-03-04 |
2000-08-02 |
バクスター インターナショナル インコーポレイテッド |
アデノウイルスe1−相補性細胞系
|
PL336523A1
(en)
|
1997-04-28 |
2000-07-03 |
Rhone Poulenc Rorer Sa |
Intraneoplastic delivery of an angiogenesis antagonist by means of adenoviruses in order to treat neoplasms
|
AU8097698A
(en)
|
1997-06-23 |
1999-01-04 |
University Of Saskatchewan |
Bovine adenovirus type 3 genome
|
AU759707B2
(en)
|
1998-01-08 |
2003-04-17 |
Aventis Pharmaceuticals Products Inc. |
A transgenic rabbit that expresses a functional human lipoprotein (A)
|
EP1056880A1
(en)
*
|
1998-02-17 |
2000-12-06 |
Genzyme Corporation |
Methods for purified aav vector production
|
FR2777570A1
(fr)
*
|
1998-04-17 |
1999-10-22 |
Transgene Sa |
Mutant ayant une activite phosphoribosyl transferase
|
US6225456B1
(en)
|
1998-05-07 |
2001-05-01 |
University Technololy Corporation |
Ras suppressor SUR-5
|
US6506889B1
(en)
|
1998-05-19 |
2003-01-14 |
University Technology Corporation |
Ras suppressor SUR-8 and related compositions and methods
|
GB9811171D0
(en)
*
|
1998-05-22 |
1998-07-22 |
Royal Free Hosp School Med |
Viral vector
|
GB9811172D0
(en)
*
|
1998-05-22 |
1998-07-22 |
Royal Free Hosp School Med |
Virus production
|
JP2002528128A
(ja)
|
1998-11-02 |
2002-09-03 |
ユニバーシティ オブ サスカチュワン |
組換えアデノウイルスベクターの増殖のためのアデノウイルス必須機能を発現するウシ細胞
|
US6441156B1
(en)
|
1998-12-30 |
2002-08-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Calcium channel compositions and methods of use thereof
|
US7960540B2
(en)
|
1999-04-08 |
2011-06-14 |
Advanced Cancer Therapeutics, Llc |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
|
US8114850B2
(en)
|
1999-04-08 |
2012-02-14 |
Advanced Cancer Therapeutics, Llc |
Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
|
PT1181304E
(pt)
|
1999-04-08 |
2008-01-23 |
Antisoma Res Ltd |
Actividade antiproliferativa de oligonucleótidos ricos em g e método de utilização dos mesmos para ligação a nucleolina
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
GB0018307D0
(en)
|
2000-07-26 |
2000-09-13 |
Aventis Pharm Prod Inc |
Polypeptides
|
CA2404688C
(en)
|
2000-03-31 |
2012-07-31 |
Aventis Pharmaceuticals Products Inc. |
Nuclear factor .kappa.b inducing factor
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
DE10044384A1
(de)
*
|
2000-09-08 |
2002-04-18 |
Medigene Ag |
Wirtszellen zur Verpackung von rekombinantem Adeno-assoziiertem Virus (rAAV), Verfahren zu ihrer Herstellung und deren Verwendung
|
KR20030074680A
(ko)
|
2000-12-28 |
2003-09-19 |
와이어쓰 |
스트렙토코커스 뉴모니에 유래 재조합 보호 단백질
|
AUPR518501A0
(en)
|
2001-05-22 |
2001-06-14 |
Unisearch Limited |
Yin yang-1
|
US6677156B2
(en)
|
2001-07-23 |
2004-01-13 |
Genvec, Inc. |
Non-adenoviral gene product-based complementing cells for adenoviral vectors
|
US6682929B2
(en)
|
2001-07-23 |
2004-01-27 |
Genvec, Inc. |
Adenovector complementing cells
|
US7647184B2
(en)
*
|
2001-08-27 |
2010-01-12 |
Hanall Pharmaceuticals, Co. Ltd |
High throughput directed evolution by rational mutagenesis
|
US20030129203A1
(en)
*
|
2001-08-27 |
2003-07-10 |
Nautilus Biotech S.A. |
Mutant recombinant adeno-associated viruses
|
US20040253210A1
(en)
*
|
2001-08-30 |
2004-12-16 |
Marjorie Robert-Guroff |
Adenovirus type7 vectors
|
US20040023910A1
(en)
*
|
2001-09-28 |
2004-02-05 |
Zhiming Zhang |
Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
US20030224404A1
(en)
*
|
2002-02-25 |
2003-12-04 |
Manuel Vega |
High throughput directed evolution of nucleic acids by rational mutagenesis
|
IL164802A0
(en)
*
|
2002-04-25 |
2005-12-18 |
Crucell Holland Bv |
Stable adenoviral vectors and methods for propagation thereof
|
WO2003097683A2
(en)
|
2002-05-15 |
2003-11-27 |
Integragen |
Human obesity susceptibility gene and uses thereof
|
KR101086533B1
(ko)
|
2002-05-24 |
2011-11-23 |
쉐링 코포레이션 |
중화 사람 항-igfr 항체, 이를 제조하는 방법 및 이를 포함하는 조성물
|
WO2004018627A2
(en)
*
|
2002-08-22 |
2004-03-04 |
Merck & Co., Inc. |
Methods for propagating adenovirus and virus produced thereby
|
DE60332358D1
(de)
*
|
2002-09-09 |
2010-06-10 |
Hanall Pharmaceutical Co Ltd |
Protease-resistente modifizierte interferon alpha polypeptide
|
US20060020396A1
(en)
*
|
2002-09-09 |
2006-01-26 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
US20050202438A1
(en)
*
|
2002-09-09 |
2005-09-15 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
CA2519680A1
(en)
|
2003-03-28 |
2004-11-18 |
The Scripps Research Institute |
Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
|
US7485291B2
(en)
*
|
2003-06-03 |
2009-02-03 |
Cell Genesys, Inc. |
Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
|
JP4644663B2
(ja)
*
|
2003-06-03 |
2011-03-02 |
セル ジェネシス インコーポレイテッド |
ペプチド開裂部位を用いた単一ベクターからの組換えポリペプチドの高められた発現のための構成と方法
|
US7186699B2
(en)
*
|
2003-06-03 |
2007-03-06 |
Cell Genesys, Inc. |
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
|
EP1649028B1
(en)
*
|
2003-07-25 |
2012-08-22 |
Genvec, Inc. |
Adenoviral vector-based vaccines
|
ATE431855T1
(de)
|
2003-08-22 |
2009-06-15 |
Integragen Sa |
Menschliches autismus-suszeptibilitätsgen und verwendungen davon
|
EP1687032B1
(en)
|
2003-11-14 |
2010-02-24 |
Genvec, Inc. |
Pharmaceutical composition for treating unresectable, locally advanced pancreatic cancer (lapc).
|
DE602004027538D1
(de)
|
2003-12-01 |
2010-07-15 |
Life Technologies Corp |
Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
|
PL2163260T3
(pl)
*
|
2004-01-23 |
2017-12-29 |
Msd Italia S.R.L. |
Szympansie adenowirusowe nośniki szczepionek
|
US7432057B2
(en)
|
2004-01-30 |
2008-10-07 |
Michigan State University |
Genetic test for PSE-susceptible turkeys
|
JP2007532656A
(ja)
|
2004-04-12 |
2007-11-15 |
アメリカ合衆国 |
アデノウイルスベクターを用いて免疫応答を誘導するための方法
|
JP2008504838A
(ja)
|
2004-07-01 |
2008-02-21 |
アンテグラジャン |
Prkcb1をコードするヒト自閉症感受性遺伝子およびその使用
|
US7604798B2
(en)
|
2004-07-15 |
2009-10-20 |
Northwestern University |
Methods and compositions for importing nucleic acids into cell nuclei
|
CA2573702C
(en)
|
2004-07-16 |
2013-10-15 |
The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services |
Vaccine constructs and combination of vaccines designed to improve the breadth of the immune response to diverse strains and clades of hiv
|
WO2006039045A2
(en)
*
|
2004-09-01 |
2006-04-13 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adenoviral vectors able to transduce apcs, potential use in immune response generation
|
US20060057127A1
(en)
*
|
2004-09-10 |
2006-03-16 |
Pocheng Liu |
Cytokine-expressing cellular vaccines for treatment of prostate cancer
|
ATE482290T1
(de)
|
2005-03-24 |
2010-10-15 |
Integragen Sa |
Ein transmembranprotein kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung
|
US20060234347A1
(en)
*
|
2005-04-13 |
2006-10-19 |
Harding Thomas C |
Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
|
PL2002003T3
(pl)
|
2005-05-27 |
2016-06-30 |
Ospedale San Raffaele Srl |
Wektor genetyczny zawierający mi-RNA
|
EP2468768A3
(en)
|
2005-07-21 |
2012-10-31 |
Abbott Laboratories |
Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis
|
US8450055B2
(en)
*
|
2005-08-31 |
2013-05-28 |
The United States Of America As Represented By The Secretary Of The Navy |
Malaria antigen screening method
|
WO2007027860A2
(en)
|
2005-08-31 |
2007-03-08 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
US9651543B2
(en)
|
2005-08-31 |
2017-05-16 |
The United States Of America As Represented By The Secretary Of The Navy |
Malaria antigen screening method
|
CA2629163C
(en)
*
|
2005-11-10 |
2017-03-21 |
Genvec, Inc. |
Adenoviral vector-based foot-and-mouth disease vaccine
|
EP1835036A1
(en)
|
2006-03-16 |
2007-09-19 |
Exonhit Therapeutics SA |
Methods and compositions for the detection and treatment of cancers
|
US20100143302A1
(en)
*
|
2006-03-16 |
2010-06-10 |
Crucell Holland B.V. |
Recombinant Adenoviruses Based on Serotype 26 and 48, and Use Thereof
|
WO2008060814A2
(en)
|
2006-10-19 |
2008-05-22 |
Merck & Co., Inc. |
ANTI-IL-13Rα1 ANTIBODIES AND THEIR USES THEREOF
|
PL2068921T3
(pl)
|
2006-10-19 |
2014-12-31 |
Csl Ltd |
Przeciwciała o dużym powinowactwie będące antagonistami receptora alfa1 interleukiny 13
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
US20100278870A1
(en)
*
|
2007-01-09 |
2010-11-04 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Adenoviral vector-based malaria vaccines
|
EP2027868A1
(en)
|
2007-08-24 |
2009-02-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of SCO-Spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands
|
ES2848323T3
(es)
|
2008-01-31 |
2021-08-06 |
Inst Nat Sante Rech Med |
Anticuerpos contra CD39 humano y uso de los mismos para inhibir la actividad de las células T reguladoras
|
WO2010040766A1
(en)
|
2008-10-07 |
2010-04-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (pf4v1)
|
DK2356135T3
(en)
|
2008-11-05 |
2017-12-04 |
Wyeth Llc |
IMMUNOGEN MULTICOMPONENT COMPOSITION FOR THE PREVENTION OF BETA-HAEMOLYTIC STRUCTURAL TOC (BHS) DISEASE
|
WO2010070137A1
(en)
|
2008-12-19 |
2010-06-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders
|
EP2199387A1
(en)
|
2008-12-19 |
2010-06-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Serine protease derivatives and uses for the prevention and/or the treatment of blood coagulation disorders
|
PT2382474E
(pt)
|
2009-01-20 |
2015-06-03 |
Transgene Sa |
Icam-1 solúvel como biomarcador para a previsão de uma resposta terapêutica
|
WO2010096561A1
(en)
|
2009-02-18 |
2010-08-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic hiv/siv gag proteins and uses thereof
|
US20120064096A1
(en)
|
2009-03-17 |
2012-03-15 |
Universite De La Mediterranee |
BTLA Antibodies and Uses Thereof
|
MX2011010061A
(es)
|
2009-03-24 |
2011-11-18 |
Transgene Sa |
Biomarcador para monitorear pacientes.
|
MX2011010920A
(es)
|
2009-04-17 |
2011-11-04 |
Transgene Sa |
Biomarcador para monitorear pacientes.
|
US9125861B2
(en)
|
2009-05-04 |
2015-09-08 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
PAR2 agonists for use in the treatment or prevention of influenza virus type A infections
|
WO2010128265A2
(fr)
|
2009-05-07 |
2010-11-11 |
Stallergenes S.A. |
Utilisation d'immunoglobulines igg1 et/ou de ligands du récepteur cd32 pour le traitement de maladies et manifestations inflammatoires par voie mucosale
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
NZ596325A
(en)
|
2009-07-10 |
2013-11-29 |
Transgene Sa |
Biomarker for selecting patients and related methods
|
US20120219583A1
(en)
|
2009-10-16 |
2012-08-30 |
Los Alamos National Security, Llc |
Nucleic acid sequences encoding expandable hiv mosaic proteins
|
WO2011048443A1
(en)
|
2009-10-20 |
2011-04-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neuronal exocytosis inhibiting peptides derived from c subunit of v-atpase and cosmetic and pharmaceutical compositions containing said peptides
|
WO2011053699A1
(en)
|
2009-10-30 |
2011-05-05 |
Abbott Laboratories |
Sorf constructs and multiple gene expression
|
WO2011057254A2
(en)
|
2009-11-09 |
2011-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Simian adenoviral vector-based vaccines
|
BR112012010824A2
(pt)
|
2009-11-09 |
2018-03-06 |
Genvec Inc |
adenovirus simios e métodos de uso
|
WO2011080322A1
(en)
|
2009-12-30 |
2011-07-07 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Method of prognosing the outcome of acquired hemophilia and of treatment of hemophilia
|
WO2011086137A1
(en)
|
2010-01-13 |
2011-07-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Promyelocytic leukemia protein as a redox sensor
|
KR20110103119A
(ko)
*
|
2010-03-12 |
2011-09-20 |
국립암센터 |
신규한 조건부-복제 가능 아데노바이러스 및 그의 제조 방법
|
US9682133B2
(en)
|
2010-03-17 |
2017-06-20 |
Cornell University |
Disrupted adenovirus-based vaccine against drugs of abuse
|
EP3741383A1
(en)
|
2010-04-08 |
2020-11-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
|
WO2011147889A1
(en)
|
2010-05-25 |
2011-12-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient
|
WO2012004416A2
(en)
|
2010-07-09 |
2012-01-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of a disease associated with retinal degenerative disorder
|
EP2596025B1
(en)
|
2010-07-23 |
2018-06-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for cancer management targeting co-029
|
WO2012021730A2
(en)
|
2010-08-11 |
2012-02-16 |
Genvec, Inc. |
Respiratory syncytial virus (rsv) vaccine
|
MX350142B
(es)
|
2010-08-23 |
2017-08-28 |
Wyeth Llc * |
Formulaciones estables de antigenos rlp2086 de neisseria meningitidis.
|
EP3549601B1
(en)
|
2010-09-10 |
2021-02-24 |
Wyeth LLC |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
ES2566495T3
(es)
|
2010-10-15 |
2016-04-13 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Vector de expresión para colesterol 24-hidrolasa en terapia de la enfermedad de Huntington
|
WO2012080769A1
(en)
|
2010-12-15 |
2012-06-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-cd277 antibodies and uses thereof
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
US8920813B2
(en)
|
2010-12-20 |
2014-12-30 |
Genvec, Inc. |
Adenoviral vector-based dengue fever vaccine
|
ES2684602T3
(es)
|
2010-12-22 |
2018-10-03 |
Orega Biotech |
Anticuerpos contra CD39 humano y uso de los mismos
|
EP2658869B1
(en)
|
2010-12-30 |
2019-06-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antigen binding formats for use in therapeutic treatments or diagnostic assays
|
WO2012101125A1
(en)
|
2011-01-24 |
2012-08-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Specific antibodies against human cxcl4 and uses thereof
|
WO2012120131A1
(en)
|
2011-03-09 |
2012-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for generating cell microparticles
|
WO2012120129A1
(en)
|
2011-03-10 |
2012-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment of infectious diseases
|
SG193428A1
(en)
|
2011-03-31 |
2013-10-30 |
Inst Nat Sante Rech Med |
Antibodies directed against icos and uses thereof
|
PT2707391T
(pt)
|
2011-05-13 |
2018-02-06 |
Inserm Institut National De La Santa© Et De La Rech Ma©Dicale |
Anticorpos contra her3
|
KR102101806B1
(ko)
|
2011-05-19 |
2020-04-20 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
항-인간-her3 항체 및 이의 용도
|
WO2012162428A1
(en)
|
2011-05-23 |
2012-11-29 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Prime-boost vaccination for viral infection
|
EP2721057B1
(en)
|
2011-06-15 |
2019-07-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer
|
KR20140104944A
(ko)
|
2011-06-22 |
2014-08-29 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
항-axl 항체 및 그의 용도
|
ES2677367T3
(es)
|
2011-06-22 |
2018-08-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anticuerpos anti-Axl y usos de los mismos
|
EP2543677A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
EP2543679A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
EP2543678A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
FR2979346B1
(fr)
|
2011-08-23 |
2013-09-27 |
Univ Joseph Fourier |
Nanocorps anti-vcam-1
|
US20140235492A1
(en)
|
2011-09-20 |
2014-08-21 |
Institut National De La Sante Et De La Recherche Medicate (Inserm) |
Methods for preparing single domain antibody microarrays
|
WO2013052859A2
(en)
|
2011-10-05 |
2013-04-11 |
Genvec, Inc. |
Adenoviral vector-based respiratory syncytial virus (rsv) vaccine
|
BR112014008284A2
(pt)
|
2011-10-05 |
2020-10-27 |
Genvec Inc. |
adenovirus (gorilla) simian ou vetores adenovirais e métodos de uso
|
BR112014008167B1
(pt)
|
2011-10-05 |
2022-05-24 |
Genvec Inc |
Adenovírus ou vetor adenoviral e composição os compreendendo
|
US9629906B2
(en)
|
2011-10-05 |
2017-04-25 |
Genvec, Inc. |
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
|
US20150157700A1
(en)
|
2012-02-02 |
2015-06-11 |
GanVec, Inc. |
Adenoviral vector-based malaria vaccine
|
CN104428009A
(zh)
|
2012-02-07 |
2015-03-18 |
全球生物疗法美国有限公司 |
核酸输送的区室化方法及其组合物和应用
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
MX359256B
(es)
|
2012-03-09 |
2018-09-19 |
Pfizer |
Composiciones de neisseria meningitidis y metodos de las mismas.
|
US10039777B2
(en)
|
2012-03-20 |
2018-08-07 |
Neuro-Lm Sas |
Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
|
WO2013174835A1
(en)
|
2012-05-22 |
2013-11-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for screening a candidate compound for its pharmacology on a nuclear receptor
|
US9605257B2
(en)
|
2012-05-25 |
2017-03-28 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods for selecting binders by phage display and masked selection
|
US9790519B2
(en)
|
2012-05-29 |
2017-10-17 |
Genvec, Inc. |
Modified serotype 28 adenoviral vectors
|
EP2855511B1
(en)
|
2012-05-29 |
2019-07-24 |
GenVec, Inc. |
Herpes simplex virus vaccine
|
EP2864355B1
(en)
|
2012-06-25 |
2016-10-12 |
Orega Biotech |
Il-17 antagonist antibodies
|
EP2692732A1
(en)
|
2012-08-03 |
2014-02-05 |
Stallergenes S.A. |
Novel allergen from ragweed pollen and uses thereof
|
US9695247B2
(en)
|
2012-09-03 |
2017-07-04 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Antibodies directed against ICOS for treating graft-versus-host disease
|
NZ705899A
(en)
|
2012-09-07 |
2018-08-31 |
Inst Nat Sante Rech Med |
Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof
|
ES2752190T3
(es)
|
2012-09-14 |
2020-04-03 |
Us Health |
Proteína Brachyury, vectores adenovirales que codifican proteína Brachyury y su uso
|
KR101522341B1
(ko)
*
|
2012-10-02 |
2015-05-21 |
국립암센터 |
신규한 조건부-복제 가능 아데노바이러스 및 그의 제조 방법
|
WO2014057134A1
(en)
|
2012-10-12 |
2014-04-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Csn5 polypeptides and uses thereof for screening therapeutic agents
|
EP2733153A1
(en)
|
2012-11-15 |
2014-05-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the preparation of immunoconjugates and uses thereof
|
MY171100A
(en)
|
2012-11-20 |
2019-09-25 |
Sanofi Sa |
Anti-ceacam5 antibodies and uses thereof
|
US11013783B2
(en)
|
2012-12-26 |
2021-05-25 |
Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement |
Anti-inflammatory peptides and methods for treating inflammatory diseases
|
EP2749289A1
(en)
|
2012-12-26 |
2014-07-02 |
Institut National De La Recherche Agronomique (INRA) |
Anti-inflammatory peptides
|
EA201591219A1
(ru)
|
2012-12-27 |
2015-12-30 |
Санофи |
Антитела против lamp1 и конъюгаты антитела и лекарственного средства, а также их применение
|
WO2014107739A1
(en)
|
2013-01-07 |
2014-07-10 |
Eleven Biotherapeutics, Inc. |
Antibodies against pcsk9
|
US9066966B2
(en)
|
2013-02-01 |
2015-06-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
|
EP2964665B1
(en)
|
2013-03-08 |
2018-08-01 |
Pfizer Inc |
Immunogenic fusion polypeptides
|
AU2014249045A1
(en)
|
2013-03-11 |
2015-10-29 |
University Of Florida Research Foundation, Inc. |
Delivery of CARD protein as therapy for occular inflammation
|
DE102013004595A1
(de)
|
2013-03-15 |
2014-09-18 |
Emergent Product Development Germany Gmbh |
RSV-Impfstoffe
|
KR101606910B1
(ko)
|
2013-03-29 |
2016-04-04 |
충북보건과학대학교 산학협력단 |
아데노바이러스 벡터 생산용 a549 기반 세포주
|
EP3013356B1
(en)
|
2013-06-27 |
2018-10-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Interleukin 15 (il-15) antagonists and uses thereof for the treatment of autoimmune diseases and inflammatory diseases
|
EP2824176A1
(en)
|
2013-07-11 |
2015-01-14 |
Siamed'xpress |
Methods for producing sialylated therapeutic proteins
|
MX2016001667A
(es)
|
2013-08-08 |
2016-11-07 |
Global Bio Therapeutics Inc |
Dispositivo de sujecion para procedimientos minimamente invasivos y usos del mismo.
|
RU2662968C2
(ru)
|
2013-09-08 |
2018-07-31 |
Пфайзер Инк. |
Иммуногенная композиция против neisseria meningitidis (варианты)
|
WO2015067668A1
(en)
|
2013-11-05 |
2015-05-14 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New alzheimer's disease animal model
|
CA2929386C
(en)
|
2013-11-07 |
2023-01-03 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Neuregulin allosteric anti-her3 antibody
|
CA2936954A1
(en)
|
2014-01-20 |
2015-07-23 |
Sanofi |
Novel cytochrome p450 polypeptide with increased enzymatic activity
|
US11053291B2
(en)
|
2014-02-19 |
2021-07-06 |
University Of Florida Research Foundation, Incorporated |
Delivery of Nrf2 as therapy for protection against reactive oxygen species
|
FR3020063A1
(fr)
|
2014-04-16 |
2015-10-23 |
Gamamabs Pharma |
Anticorps humain anti-her4
|
US10544231B2
(en)
|
2014-04-16 |
2020-01-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the prevention or the treatment of bleeding episodes
|
WO2015158810A1
(en)
|
2014-04-17 |
2015-10-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Polypeptides and uses thereof for reducing cd95-mediated cell motility
|
FR3021970B1
(fr)
|
2014-06-06 |
2018-01-26 |
Universite Sciences Technologies Lille |
Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
|
EP2974735A1
(en)
|
2014-07-15 |
2016-01-20 |
Institut National De La Recherche Agronomique (INRA) |
Anti-inflammatory properties of a surface protein of propionibacterium freudenreichii
|
EP3189067B1
(en)
|
2014-09-04 |
2021-05-19 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Recombinant hiv-1 envelope proteins and their use
|
JP6864953B2
(ja)
|
2014-12-09 |
2021-04-28 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Axlに対するヒトモノクローナル抗体
|
WO2016103238A1
(en)
|
2014-12-24 |
2016-06-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant metapneumovirus f proteins and their use
|
CA2974359A1
(en)
|
2015-01-20 |
2016-07-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant parainfluenza virus expressing a chimeric f protein and uses thereof
|
TW202130662A
(zh)
|
2015-01-23 |
2021-08-16 |
法商賽諾菲公司 |
特異性結合cd3及/或cd123之抗—cd3抗體,抗—cd123抗體及雙特異性抗體
|
CN107249626A
(zh)
|
2015-02-19 |
2017-10-13 |
辉瑞大药厂 |
脑膜炎奈瑟球菌组合物及其方法
|
US10301377B2
(en)
|
2015-02-24 |
2019-05-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
|
WO2016135041A1
(en)
|
2015-02-26 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and antibodies comprising thereof for promoting apoptosis
|
EP3273999A1
(en)
|
2015-03-23 |
2018-01-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with friedreich ataxia
|
EP3091033A1
(en)
|
2015-05-06 |
2016-11-09 |
Gamamabs Pharma |
Anti-human-her3 antibodies and uses thereof
|
US20180125947A1
(en)
|
2015-05-20 |
2018-05-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of retinal detachment
|
ES2898023T3
(es)
|
2015-05-22 |
2022-03-03 |
Inst Nat Sante Rech Med |
Fragmentos de anticuerpos monoclonales humanos que inhiben tanto la actividad catalítica de Cath-D como su unión al receptor LRP1
|
EP3319990A1
(en)
|
2015-07-07 |
2018-05-16 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Antibodies having specificity to myosin 18a and uses thereof
|
CA2994694A1
(en)
|
2015-08-03 |
2017-02-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use
|
WO2017029391A1
(en)
|
2015-08-20 |
2017-02-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating cancer
|
US10858452B2
(en)
|
2015-09-16 |
2020-12-08 |
Insitut National de la Sante et de la Recherche Medicale (INSERM) |
Specific interleukin-15 (IL-15) antagonist polypeptide and uses thereof for the treatment of inflammatory and auto-immune diseases
|
WO2017050793A1
(en)
|
2015-09-22 |
2017-03-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Polypeptides capable of inhibiting the binding between leptin and neuropilin-1
|
WO2017050955A1
(en)
|
2015-09-24 |
2017-03-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Agents capable of inhibiting the binding between leptin and vegf165
|
AU2016328279A1
(en)
|
2015-09-24 |
2018-05-10 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for reducing metastases
|
US11065347B2
(en)
|
2016-01-19 |
2021-07-20 |
The Regents Of The University Of California |
Methods for the treatment of Danon disease and other disorders of autophagy
|
WO2017139392A1
(en)
|
2016-02-08 |
2017-08-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant hiv-1 envelope proteins and their use
|
MX2018010295A
(es)
|
2016-02-26 |
2019-06-06 |
Inst Nat Sante Rech Med |
Anticuerpos que tienen especificidad para atenuador de linfocitos b y t (btla) y usos de los mismos.
|
EP3426291A1
(en)
|
2016-03-09 |
2019-01-16 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Recombinant hiv-1 envelope proteins and their use
|
KR102438140B1
(ko)
|
2016-03-22 |
2022-08-31 |
엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔 |
인간화 항-클라우딘-1 항체 및 이의 용도
|
EP4159867A1
(en)
|
2016-03-28 |
2023-04-05 |
Ultragenyx Pharmaceutical Inc. |
Methods of heat inactivation of adenovirus
|
US20190290710A1
(en)
*
|
2016-07-12 |
2019-09-26 |
Dimension Therapeutics, Inc. |
Use of glucocorticoid analogs to enhance recombinant adeno-associated virus yield
|
TWI790206B
(zh)
|
2016-07-18 |
2023-01-21 |
法商賽諾菲公司 |
特異性結合至cd3和cd123的雙特異性抗體樣結合蛋白
|
US11186634B2
(en)
|
2016-07-29 |
2021-11-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies targeting tumor associated macrophages and uses thereof
|
JP2019531090A
(ja)
|
2016-09-14 |
2019-10-31 |
ウニベルシテ カソリーク デ ルーベン |
改変されたvsv−gおよびそのワクチン
|
EP3515480A1
(en)
|
2016-09-20 |
2019-07-31 |
Boehringer Ingelheim Vetmedica GmbH |
New swine influenza vaccine
|
UY37406A
(es)
|
2016-09-20 |
2018-03-23 |
Boehringer Ingelheim Vetmedica Gmbh |
Nuevo sitio de inserción orf70 de ehv
|
CA3036293A1
(en)
|
2016-09-20 |
2018-03-29 |
Boehringer Ingelheim Vetmedica Gmbh |
New promoters
|
CN109715219B
(zh)
|
2016-09-20 |
2024-03-01 |
勃林格殷格翰动物保健有限公司 |
犬腺病毒载体
|
US11155832B2
(en)
|
2016-09-30 |
2021-10-26 |
Genvec, Inc. |
Adenovectors for delivery of therapeutic genetic material into T cells
|
EP3518968B1
(en)
|
2016-10-03 |
2022-01-05 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Hiv-1 env fusion peptide immunogens and their use
|
EP3526321A4
(en)
|
2016-10-14 |
2020-05-13 |
Ultragenyx Pharmaceutical Inc. |
USE OF TONIFYING AGENTS TO IMPROVE THE YIELD OF RECOMBINANT ADENO-ASSOCIATED VIRUS
|
TWI778985B
(zh)
|
2016-10-20 |
2022-10-01 |
法商賽諾菲公司 |
抗chikv抗體及其用途
|
EP3532095A1
(en)
|
2016-10-25 |
2019-09-04 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Prefusion coronavirus spike proteins and their use
|
JP2019535306A
(ja)
|
2016-10-25 |
2019-12-12 |
インセルム(インスティチュート ナショナル デ ラ サンテ エ デ ラリシェルシェ メディカル) |
Cd160膜貫通型アイソフォームと結合するモノクローナル抗体
|
FR3058143B1
(fr)
|
2016-10-27 |
2021-03-12 |
Univ Grenoble Alpes |
Nanocorps anti-tau
|
BR112019009446A2
(pt)
|
2016-11-09 |
2019-07-30 |
Intrexon Corp |
construtos de expressão da frataxina
|
CA3043790A1
(en)
|
2016-12-16 |
2018-06-21 |
Institute For Research In Biomedicine |
Novel recombinant prefusion rsv f proteins and uses thereof
|
HUE061905T2
(hu)
|
2017-01-30 |
2023-08-28 |
Brainvectis |
Expresszós vektor koleszterin-24-hidrolázhoz, poliglutamin-ismétlõdéses spinocerebelláris ataxiák kezelésében
|
SG11201906519RA
(en)
|
2017-01-31 |
2019-08-27 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
US11274160B2
(en)
|
2017-03-02 |
2022-03-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale |
Antibodies having specificity to Nectin-4 and uses thereof
|
CA3051640A1
(en)
|
2017-03-16 |
2018-09-20 |
Innate Pharma |
Compositions and methods for treating cancer
|
WO2018175775A1
(en)
|
2017-03-22 |
2018-09-27 |
Dimension Therapeutics |
Cell culture methods involving hdac inhibitors or rep proteins
|
WO2018176031A1
(en)
|
2017-03-24 |
2018-09-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Glycan-masked engineered outer domains of hiv-1 gp120 and their use
|
WO2018178051A1
(en)
|
2017-03-28 |
2018-10-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Scgb1a1 polymorphism for the prediction and therapy or prevention of primary graft dysfunction
|
EP3388072A1
(en)
|
2017-04-10 |
2018-10-17 |
Universität Leipzig |
Ubiquinone-independent cytoplasmic dihydroorotate dehydrogenase for use as medicament
|
CN110914414A
(zh)
|
2017-06-14 |
2020-03-24 |
德累斯顿工业大学 |
利用设计dna重组酶遗传改变基因组的方法与手段
|
US11174322B2
(en)
|
2017-07-24 |
2021-11-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies and peptides to treat HCMV related diseases
|
WO2019038420A1
(en)
|
2017-08-25 |
2019-02-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOCLAST DISEASES
|
KR20200133323A
(ko)
|
2017-09-21 |
2020-11-27 |
임체크 테라퓨틱스 에스에이에스 |
Btn2에 대해 특이성을 갖는 항체 및 이의 용도
|
US11136356B2
(en)
|
2017-10-16 |
2021-10-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant HIV-1 envelope proteins and their use
|
EP3697908A1
(en)
|
2017-10-16 |
2020-08-26 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
TWI804518B
(zh)
|
2017-10-16 |
2023-06-11 |
美商航海家醫療公司 |
肌萎縮性脊髓側索硬化症(als)之治療
|
US12036257B2
(en)
|
2017-10-31 |
2024-07-16 |
Kalivir Immunotherapeutics, Inc. |
Platform oncolytic vector for systemic delivery
|
EP3762010A4
(en)
|
2018-03-06 |
2022-04-06 |
Precigen, Inc. |
HEPATITIS B VACCINES AND USES THEREOF
|
EA202092518A1
(ru)
|
2018-06-18 |
2021-08-23 |
Иннейт Фарма |
Композиции и способы лечения рака
|
WO2020010042A1
(en)
|
2018-07-02 |
2020-01-09 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
US20210361318A1
(en)
|
2018-07-02 |
2021-11-25 |
Voyager Therapeutics, Inc. |
Cannula system and use thereof
|
WO2020086483A1
(en)
|
2018-10-22 |
2020-04-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant gp120 protein with v1-loop deletion
|
FI3873511T3
(fi)
|
2018-10-29 |
2023-01-31 |
|
Ekspressiovektori kolesteroli-24-hydrolaasille amyotroofisen lateraaliskleroosin hoitoon
|
WO2020148207A1
(en)
|
2019-01-14 |
2020-07-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies binding to hla-a2
|
EP3911670A1
(en)
|
2019-01-15 |
2021-11-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Mutated interleukin-34 (il-34) polypeptides and uses thereof in therapy
|
CA3134122A1
(en)
|
2019-03-20 |
2020-09-24 |
Imcheck Therapeutics Sas |
Antibodies having specificity for btn2 and uses thereof
|
WO2020193441A1
(en)
|
2019-03-22 |
2020-10-01 |
Université de Paris |
New inhibitors of lrrk2/pp1 interaction
|
WO2020193520A1
(en)
|
2019-03-25 |
2020-10-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of taupathy disorders by targeting new tau species
|
US20220251232A1
(en)
|
2019-05-20 |
2022-08-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Novel anti-cd25 antibodies
|
CA3140809A1
(en)
|
2019-05-21 |
2020-11-26 |
Inserm (Institut De La Sante Et De La Recherche Medicale) |
Expression vector for cholesterol 24-hydrolase in therapy of rett syndrome
|
WO2020254619A1
(en)
|
2019-06-20 |
2020-12-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti- protease nexin-1 conformational single domain antibodies and uses thereof
|
US20220251567A1
(en)
|
2019-07-10 |
2022-08-11 |
Inserm (Institut National De La Santè Et De La Recherche Médicale) |
Methods for the treatment of epilepsy
|
CN114258401A
(zh)
|
2019-07-16 |
2022-03-29 |
Inserm(法国国家健康医学研究院) |
对cd38具有特异性的抗体及其用途
|
WO2021009299A1
(en)
|
2019-07-17 |
2021-01-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Bcl-xl:fkbp12 fusion proteins suitable for screening agents capable of slowing down the aging process
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
WO2021023624A1
(en)
|
2019-08-02 |
2021-02-11 |
Orega Biotech |
Novel il-17b antibodies
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
US11414785B2
(en)
|
2019-08-13 |
2022-08-16 |
Waters Technologies Corporation |
Affinity resins and sample preparation devices based on cartilaginous fish IgNAR derived binding domains
|
EP4025206A1
(en)
|
2019-09-02 |
2022-07-13 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods and compositions for treating pax6- deficiency related disease
|
US20230002497A1
(en)
|
2019-09-04 |
2023-01-05 |
Inserm (Institut National De La Santè Et De La Recherch Médicale |
Antibodies specific for il20-rb and uses thereof for the treatment of acute exacerbation of chronic obstructive pulmonary disease
|
WO2021048171A1
(en)
|
2019-09-10 |
2021-03-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method to improve phagocytosis
|
AU2020356334A1
(en)
|
2019-09-24 |
2022-03-31 |
Université Catholique de Louvain |
Modified vesicular stomatitis virus glycoprotein and uses thereof for the treatment of brain tumors
|
CN114450304B
(zh)
|
2019-09-27 |
2023-12-12 |
国家医疗保健研究所 |
抗苗勒管抑制物质抗体及其用途
|
WO2021058729A1
(en)
|
2019-09-27 |
2021-04-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-müllerian inhibiting substance type i receptor antibodies and uses thereof
|
KR20220076510A
(ko)
|
2019-10-08 |
2022-06-08 |
트러스티스 오브 보스톤 칼리지 |
다수의 서로 다른 비천연 아미노산을 함유하는 단백질 및 이러한 단백질의 제조 및 사용 방법
|
EP3812008A1
(en)
|
2019-10-23 |
2021-04-28 |
Gamamabs Pharma |
Amh-competitive antagonist antibody
|
CN110656090B
(zh)
*
|
2019-10-28 |
2023-06-30 |
嘉兴安宇生物科技有限公司 |
一种表达质粒、用于包装容量增加的二代腺病毒的细胞株及其应用
|
CN110714027A
(zh)
*
|
2019-10-28 |
2020-01-21 |
嘉铭(固安)生物科技有限公司 |
一种表达质粒、用于包装二代腺病毒的细胞株及其应用
|
US20230016983A1
(en)
|
2019-11-19 |
2023-01-19 |
lNSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) |
Antisense oligonucleotides and thier use for the treatment of cancer
|
WO2021099576A1
(en)
|
2019-11-21 |
2021-05-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Novel immunotherapies targeting pd-1 with anti-pd-1/il-15 immunocytokines
|
WO2021116119A1
(en)
|
2019-12-09 |
2021-06-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to her4 and uses thereof
|
EP4090365A1
(en)
|
2020-01-15 |
2022-11-23 |
Immatics Biotechnologies GmbH |
Antigen binding proteins specifically binding prame
|
CN115697388A
(zh)
|
2020-01-30 |
2023-02-03 |
优莫佳生物制药股份有限公司 |
双特异性转导增强子
|
JP2023513693A
(ja)
|
2020-02-11 |
2023-04-03 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
SARS-CoV-2ワクチン
|
WO2021175954A1
(en)
|
2020-03-04 |
2021-09-10 |
Imcheck Therapeutics Sas |
Antibodies having specificity for btnl8 and uses thereof
|
AU2021357520A1
(en)
|
2020-03-05 |
2022-09-29 |
Neotx Therapeutics Ltd. |
Methods and compositions for treating cancer with immune cells
|
US11213482B1
(en)
|
2020-03-05 |
2022-01-04 |
University of Pittsburgh—Of the Commonwealth System of Higher Educat |
SARS-CoV-2 subunit vaccine and microneedle array delivery system
|
US11773391B2
(en)
|
2020-04-01 |
2023-10-03 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Therapeutic and diagnostic target for SARS-CoV-2 and COVID-19
|
CN116096407A
(zh)
|
2020-04-29 |
2023-05-09 |
美国政府(由卫生和人类服务部的部长所代表) |
重组人偏肺病毒f蛋白及其用途
|
KR20230008751A
(ko)
|
2020-05-12 |
2023-01-16 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
피부 t-세포 림프종 및 tfh 유래된 림프종을 치료하는 신규한 방법
|
WO2021247995A2
(en)
|
2020-06-04 |
2021-12-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating neuropathic pain
|
JP2023532726A
(ja)
|
2020-06-29 |
2023-07-31 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) |
抗プロテインsシングルドメイン抗体及びそれを含むポリペプチド
|
EP4192487A1
(en)
|
2020-08-07 |
2023-06-14 |
Spacecraft Seven, LLC |
Plakophilin-2 (pkp2) gene therapy using aav vector
|
WO2022035860A2
(en)
|
2020-08-10 |
2022-02-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Replication-competent adenovirus type 4-hiv env vaccines and their use
|
CN116113439A
(zh)
|
2020-09-04 |
2023-05-12 |
默克专利股份公司 |
抗ceacam5抗体和缀合物及其用途
|
JP2023554587A
(ja)
|
2020-11-12 |
2023-12-28 |
アンセルム(アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル) |
Sars-cov-2 スパイクタンパク質の受容体結合ドメインにコンジュゲートまたは融合している抗体およびワクチン目的でのそれらの使用
|
US20240131138A1
(en)
|
2020-12-23 |
2024-04-25 |
Institut National De La Santé Et De La Recherche Médicale (Inserm) |
Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells
|
WO2022152698A1
(en)
|
2021-01-12 |
2022-07-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of npdk-d to evaluate cancer prognosis
|
JP2024504696A
(ja)
|
2021-01-20 |
2024-02-01 |
バイオアントレ エルエルシー |
Ctla4結合性タンパク質およびがんを処置する方法
|
AU2022212952A1
(en)
|
2021-01-27 |
2023-08-10 |
Umoja Biopharma, Inc. |
Lentivirus for generating cells expressing anti-cd19 chimeric antigen receptor
|
JP2024504195A
(ja)
|
2021-01-29 |
2024-01-30 |
アンセルム(アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル) |
クラミジア・トラコマチス抗原性ポリペプチドおよびワクチン目的のためのその使用
|
WO2022184805A1
(en)
|
2021-03-03 |
2022-09-09 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding sars-cov-2 antigenic peptides in complex with a major histocompatibility complex protein
|
WO2022200469A1
(en)
|
2021-03-24 |
2022-09-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
A dominant negative protein of rad51 for treating cancer
|
EP4322937A1
(en)
|
2021-04-14 |
2024-02-21 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
New method to improve the anti-tumoral activity of macrophages
|
US20240228659A1
(en)
|
2021-04-14 |
2024-07-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to improve nk cells cytotoxicity
|
WO2022232648A1
(en)
|
2021-04-29 |
2022-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Prefusion-stabilized lassa virus glycoprotein complex and its use
|
BR112023022681A2
(pt)
|
2021-04-30 |
2024-01-23 |
Kalivir Immunotherapeutics Inc |
Vírus oncolíticos para expressão modificada de mhc
|
JP2024518378A
(ja)
|
2021-05-05 |
2024-05-01 |
イマティクス バイオテクノロジーズ ゲーエムベーハー |
Prameに特異的に結合する抗原結合タンパク質
|
WO2022238974A1
(en)
|
2021-05-13 |
2022-11-17 |
Universidade Do Algarve |
Isolated or artificial nucleotide sequences for use in neurodegenerative diseases
|
IL310374A
(en)
|
2021-07-27 |
2024-03-01 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins that uniquely bind CT45
|
EP4381069A1
(en)
|
2021-08-02 |
2024-06-12 |
Universite De Montpellier |
Compositions and methods for treating cmt1a or cmt1e diseases with rnai molecules targeting pmp22
|
AU2022323509A1
(en)
|
2021-08-03 |
2024-02-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv-1 vaccination and samt-247 microbicide to prevent hiv-1 infection
|
EP4130038A1
(en)
|
2021-08-03 |
2023-02-08 |
Institut national de recherche pour l'agriculture, l'alimentation et l'environnement |
Anti-il-2 antibody, complex comprising it, and uses thereof
|
WO2023017494A1
(en)
|
2021-08-13 |
2023-02-16 |
Triovance Holding Llc |
A skin substitute composition and methods of producing and using the same
|
US20230241118A1
(en)
|
2021-10-20 |
2023-08-03 |
University Of Rochester |
Rejuvenation treatment of age-related white matter loss
|
US20230270818A1
(en)
|
2021-11-02 |
2023-08-31 |
University Of Rochester |
Tcf7l2 mediated remyelination in the brain
|
CN118234856A
(zh)
|
2021-11-15 |
2024-06-21 |
德累斯顿工业大学 |
用于有效且特异性基因组编辑的位点特异性重组酶
|
KR20240103030A
(ko)
|
2021-11-17 |
2024-07-03 |
인스티튜트 내셔날 드 라 싼테 에 드 라 리셰르셰 메디칼르 |
범용 사르베코바이러스 백신
|
WO2023091696A1
(en)
|
2021-11-19 |
2023-05-25 |
Christiana Care Gene Editing Institute, Inc. |
Adenovirus delivery system for cancer treatment
|
WO2023099578A1
(en)
|
2021-12-01 |
2023-06-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neutralizing anti-cd95l monoclonal antibodies
|
EP4209508A1
(en)
|
2022-01-11 |
2023-07-12 |
Centre national de la recherche scientifique |
Nanobodies for the deneddylating enzyme nedp1
|
WO2023150563A1
(en)
|
2022-02-01 |
2023-08-10 |
Cornell University |
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy associated with friedreich ataxia
|
WO2023156437A1
(en)
|
2022-02-16 |
2023-08-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-robo4 human monoclonal antibodies and uses thereof for the treatment of cancer
|
WO2023161412A1
(en)
|
2022-02-25 |
2023-08-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for preventing the cleavage of cd95l by metalloproteases
|
TW202346354A
(zh)
|
2022-03-09 |
2023-12-01 |
德商馬克專利公司 |
抗ceacam5抗體及其結合物及用途
|
WO2023170296A1
(en)
|
2022-03-11 |
2023-09-14 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Nucleic acid system to specifically reprogram b and t cells and uses thereof
|
WO2023192835A1
(en)
|
2022-03-27 |
2023-10-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Base-covered hiv-1 envelope ectodomains and their use
|
WO2023196898A1
(en)
|
2022-04-07 |
2023-10-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Beta globin mimetic peptides and their use
|
WO2023217904A1
(en)
|
2022-05-10 |
2023-11-16 |
Institut National de la Santé et de la Recherche Médicale |
Syncitin-1 fusion proteins and uses thereof for cargo delivery into target cells
|
WO2023240287A1
(en)
|
2022-06-10 |
2023-12-14 |
Bioentre Llc |
Combinations of ctla4 binding proteins and methods of treating cancer
|
WO2024011237A1
(en)
|
2022-07-08 |
2024-01-11 |
Cornell University |
Methods and pharmaceutical compositions for the treatment and the prevention of alzheimers disease
|
WO2024017990A1
(en)
|
2022-07-21 |
2024-01-25 |
Institut National de la Santé et de la Recherche Médicale |
Methods and compositions for treating chronic pain disorders
|
WO2024052503A1
(en)
|
2022-09-08 |
2024-03-14 |
Institut National de la Santé et de la Recherche Médicale |
Antibodies having specificity to ltbp2 and uses thereof
|
WO2024056668A1
(en)
|
2022-09-12 |
2024-03-21 |
Institut National de la Santé et de la Recherche Médicale |
New anti-itgb8 antibodies and its uses thereof
|
WO2024061930A1
(en)
|
2022-09-22 |
2024-03-28 |
Institut National de la Santé et de la Recherche Médicale |
New method to treat and diagnose peripheral t-cell lymphoma (ptcl)
|
WO2024074571A1
(en)
|
2022-10-05 |
2024-04-11 |
Institut National de la Santé et de la Recherche Médicale |
Dc-targeting vaccine against nipah virus infection
|
WO2024079317A1
(en)
|
2022-10-14 |
2024-04-18 |
Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical composition for the treatment of alpha-synucleinopathies
|
PT118269A
(pt)
|
2022-10-20 |
2024-04-22 |
Univ Aveiro |
Pkmyt1 for use in regenerative medicine
|
WO2024091824A1
(en)
|
2022-10-26 |
2024-05-02 |
Ada Forsyth Institute, Inc. |
Differentiation and reprogramming of chondrocyte
|
WO2024097992A2
(en)
|
2022-11-04 |
2024-05-10 |
Umoja Biopharma, Inc. |
Particles displaying adhesion-molecule fusions
|
WO2024098028A2
(en)
|
2022-11-04 |
2024-05-10 |
Umoja Biopharma, Inc. |
Lentiviral particles displaying fusion molecules and uses thereof
|
WO2024146935A1
(en)
|
2023-01-06 |
2024-07-11 |
Institut National de la Santé et de la Recherche Médicale |
Intravenous administration of antisense oligonucleotides for the treatment of pain
|